Fun

Search documents
X @Investopedia
Investopedia· 2025-06-25 14:30
Learn about how mutual fund sales and other types of transactions are taxed within an IRA, and discover if a sale triggers an early withdrawal penalty. https://t.co/xdQMPat6Ad ...
Dorian LPG (LPG) Earnings Call Presentation
2025-06-25 12:54
Capital Link Webinar January 2024 1 Disclaimer Forward-Looking Statements This presentation contains certain forward-looking statements including analyses and other information based on forecasts of future results and estimates of amounts not yet determinable and statements relating to our future prospects, developments and business strategies. Forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," ...
Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus
Globenewswire· 2025-06-25 11:30
Qilu Pharmaceutical and Arbutus mutually agree to conclude strategic partnership for imdusiran in Greater China Drs. Jordan Feld, Ed Gane, Anna Lok, Mark Sulkowski and Man-Fung Yuen join Arbutus Scientific Advisory Board WARMINSTER, Pa., June 25, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that it has reacquired China rights to its lead compound, imdusiran, from ...
雨季来临食用菌产销两旺!今年已注册相关企业6.4万家
Qi Cha Cha· 2025-06-25 03:19
企查查数据显示,从经营时间来看,成立年限在1-3年的食用菌相关企业最多,占比达43.27%。其次, 成立年限在1年内、10年以上的相关企业分别占比18.89%、4.92%。 3.超八成相关企业归属于农、林、牧、渔业 1.现存食用菌相关企业72.04万家 企查查数据显示,国内现存食用菌相关企业72.04万家。近十年相关企业注册量呈整体增长态势,2023 年全年注册19.79万家相关企业,达近十年注册量峰值。2024年全年注册15.73万家相关企业,较前一年 虽有所下滑,但仍处于高位。截至目前,今年已注册6.4万家食用菌相关企业。 2.成立年限在1-3年的食用菌相关企业最多 (原标题:雨季来临食用菌产销两旺!今年已注册相关企业6.4万家) 随着雨季的到来,云南野生菌即将迎来产销旺季。据媒体报道,位于昆明市官渡区的云南木水花野生菌 交易中心交易量大增。牛肝菌、鸡枞、松茸、青头菌等深受食客喜爱的"明星"菌批量上市,价格有所下 降,吸引大批本地居民和外地游客前来选购。近年来,随着野生菌产业的不断发展,催生了很多新职 业,包括洗菌工、刮菌工、鉴定师等。 企查查数据显示,国内现存食用菌相关企业72.04万家。近十年相关企业 ...
EOG Resources, Inc. (EOG) Presents at J.P. Morgan 2025 Energy, Power, Renewables & Mining Conference Transcript
Seeking Alpha· 2025-06-24 21:47
Core Viewpoint - EOG Resources is actively monitoring the macroeconomic environment, particularly in relation to geopolitical volatility and its impact on oil and gas supply and demand fundamentals [4]. Group 1: Company Insights - EOG Resources has been a significant player in the U.S. shale revolution, indicating its influential role in the energy sector [1]. - The company has made several noteworthy announcements recently, reflecting its ongoing developments and strategic direction [2]. Group 2: Industry Analysis - The demand for oil and gas appears strong globally, although there are concerns regarding how tariffs may influence this demand [4][5]. - EOG's team is closely analyzing the macro environment, which has been characterized by volatility, necessitating a careful assessment of supply and demand dynamics [4].
From Poker to the Trading Floor
Bloomberg Originals· 2025-06-24 18:00
Well, I was a poker player first and then I went from poker to finance. So, did you see similarities. Yeah, I mean, there's lots of similarities between poker and running a hedge fund.Uh, in both disciplines, you have to constantly be asking yourself, where does the money come from. Every strategy that we build at our firm, the basis of the strategy is some player in markets that we think is doing something non-economic. So, it's not necessarily like they're making a mistake, but they're they're buying or s ...
Plymouth Acquires Portfolio of Industrial Properties in Ohio
ZACKS· 2025-06-24 17:16
Key Takeaways PLYM acquired a portfolio of industrial properties in Ohio for $193M, totaling 1.95 million square feet. The acquisition strengthens PLYM's regional footprint and aligns with its acquisition strategy. The portfolio is 97% leased, with in-place rents 22% below market rates, offering lease-upside potential.Plymouth Industrial REIT (PLYM) recently announced the acquisition of a portfolio of industrial properties across Columbus, Cincinnati and Cleveland, OH for $193 million. It comprises 21 bui ...
Reimagining life through the lense of death | Svenja Krüger | TEDxInnsbruck
TEDx Talks· 2025-06-24 15:53
I'm 15 years old, sitting on my bed. My dad walks into my room. He sits down beside me and something feels different. He's quiet. Too quiet. He looks at me and I see tears in his eyes. Tears I don't ever remember seeing before. I'm not going to tell you what to do, he says softly. But family matters, Svena. Family is the most important thing. I had asked him earlier that day if I could skip our family dinner to have dinner with my boyfriend instead. I was freshly in love. There would be more family dinners, ...
AG Mortgage Investment Trust: Net Interest Income Growth To Support Dividend Hikes
Seeking Alpha· 2025-06-24 12:58
I ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets and the economy that has not faded despite the years. More recently I have been combining long stock positions with covered calls and cash secured puts. I approach investing purely from a fundamental long-term point of view. On Seeking Alpha I mostly cover REITs and financials, with occasional articles on ETFs and other stocks driven by a macro trade idea.Analyst’s D ...
Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with RAS-Addicted Cancers
Globenewswire· 2025-06-24 11:00
REDWOOD CITY, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it has partnered with Royalty Pharma on $2 billion in flexible funding to support Revolution Medicines' independent global development and commercialization strategy and operations. Revolution Medicines retains full strategic and executional control of product development and commer ...